AC Immune (ACIU) Current Assets (2014 - 2026)

AC Immune (ACIU) has reported Current Assets for 12 consecutive years, with $102.2 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Current Assets rose 60314.5% year-over-year to $102.2 billion; the TTM figure through Mar 2026 stood at $102.2 billion (up 60314.5% YoY), while the FY2025 annual figure was $116.7 billion, up 59318.45% from the prior year.
• Current Assets slipped to $102.2 billion in Q1 2026 per ACIU's latest filing, from $121.0 billion in the prior quarter.
• Across five years, Current Assets topped out at $191.7 billion in Q1 2022 and bottomed at $97.6 million in Q3 2023.
• Historically, Current Assets has averaged $42.5 billion across 5 years, with a median of $169.2 million in 2025.
• Annual changes were most pronounced in 2022 — Current Assets sank 99.94% — and 2023, when it jumped 106012.48%.
• AC Immune's Current Assets stood at $133.0 million in 2022, then surged by 106012.48% to $141.1 billion in 2023, then slumped by 99.86% to $196.3 million in 2024, then soared by 61537.35% to $121.0 billion in 2025, then dropped by 15.52% to $102.2 billion in 2026.
• Business Quant data shows ACIU's Current Assets at $102.2 billion in Q1 2026, $121.0 billion in Q4 2025, and $142.2 million in Q3 2025.